A pilot study on intermittent every other days of 5-dose Filgrastim compared with single Pegfilgrastim in breast Cancer patients receiving adjuvant Docetaxel, doxorubicin, and cyclophosphamide (TAC) chemotherapy
Keyword(s):
Keyword(s):
2017 ◽
Vol 17
(2)
◽
pp. 133-146
◽
Keyword(s):
Keyword(s):
2020 ◽
Vol 108
(3)
◽
pp. e77-e78
Keyword(s):
Keyword(s):
2013 ◽
Vol 13
(1)
◽
Keyword(s):
Keyword(s):